Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1

Arch Ophthalmol. 1997 Jul;115(7):926-7. doi: 10.1001/archopht.1997.01100160096021.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Cornea / drug effects
  • Cornea / innervation*
  • Cornea / pathology
  • Corneal Diseases / drug therapy*
  • Corneal Diseases / etiology
  • Corneal Diseases / surgery
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / therapeutic use*
  • Keratoplasty, Penetrating
  • Ophthalmic Solutions
  • Substance P / administration & dosage
  • Substance P / therapeutic use*
  • Tears / metabolism
  • Trigeminal Nerve / drug effects*

Substances

  • Ophthalmic Solutions
  • Substance P
  • Insulin-Like Growth Factor I